本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

10.40
-0.2050-1.93%
盘后:10.30-0.0950-0.91%19:30 EDT
成交量:121.29万
成交额:1,263.77万
市值:9.23亿
市盈率:-3.09
高:10.68
开:10.60
低:10.31
收:10.60
52周最高:13.90
52周最低:7.36
股本:8,877.44万
流通股本:7,060.22万
量比:0.89
换手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
净资产收益率:-167.71%
总资产收益率:-31.30%
市净率:19.05
市盈率(LYR):-3.27

数据加载中...

2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/02

重要事件披露

Form 8-K - Current report
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]